跳至主要内容
临床试验/NL-OMON45439
NL-OMON45439已完成不适用

Study on the relationship between genes and disease severity, disease burden and effectiveness of disease modifying medication in Dutch patients with Multiple Sclerosis - GEMS study - Genetic Etiology of Multiple Sclerosis

Drug Target ID, Ltd.0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • 600 Dutch patients with MS from six MS centres. We estimate that approximately 100 patients per centre will participate in the study, which is a feasible number of patients according to the neurologists of the respective centres.;In order to be eligible to participate in this study, subjects must meet all of the following criteria:
  • - diagnosed with MS for at least one year
  • - able and willing to participate in the study
  • - Dutch and from caucasian origin
  • - between 20 and 60 years of age;In addition, we are aiming for the gender distribution of our subjects to reflect the epidemiological findings for MS, i.e. approximately 35 % male and 65 % female subjects.

排除标准

  • Not applicable.

研究者

发起方
Drug Target ID, Ltd.

相似试验